Giulia Zamagni: Critical Gaps in Machine Learning Models for Fetal Growth Restriction
Giulia Zamagni, PhD Candidate in Applied data Science and Artificial Intelligence at Università degli Studi di Trieste, shared a post on LinkedIn about a paper published in American Journal of Obstetrics and Gynecology MFM:
“I’m happy to share our latest work, published in American Journal of Obstetrics and Gynecology MFM: ‘Assessing Adherence to TRIPOD+AI Guidelines in Machine Learning Models for Predicting Small for Gestational Age and Fetal Growth Restriction: A Systematic Review’.
What did we find?
Despite the growing enthusiasm for machine learning in perinatal medicine, our systematic review reveals several critical gaps that limit clinical applicability:
Not a single model evaluated performance across clinically relevant subgroups. This means we have no idea whether these models behave differently – and potentially inequitably – for different populations.
Only 15% of studies evaluated calibration.
This is perhaps the most alarming finding.
In clinical prediction models, calibration is essential: predicted risks directly inform decisions such as surveillance intensity, timing of delivery, or need for intervention.
A model that is well-discriminating but poorly calibrated can overestimate or underestimate risks, leading to unnecessary interventions or missed opportunities for timely care. Yet, calibration was almost entirely overlooked.
Why this matters
Developing ML for healthcare must be more than a technical exercise: it requires robust methodology and thoughtful evaluation to truly support patient care.”
Title: Assessing adherence to TRIPOD+AI guidelines in machine learning models for predicting small for gestational age and fetal growth restriction: a systematic review
Authors: Giulia Zamagni, Camilla Fregona, Moira Barbieri, Maria Sole Scalia, Lorenzo Monasta, Christoph Lees, Tamara Stampalija, Giulia Barbati
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Jan 28, 2026, 16:59Unlocking the Potential of Menstrual Blood in Health Testing – Global Women’s Health Innovation Conclave
-
Jan 28, 2026, 16:57New Insights on Oocyte Yield in Endometriosis and PCOM – RBMO
-
Jan 28, 2026, 16:51Transform Your Expertise with ESHRE eCampus Learning – ESHRE
-
Jan 28, 2026, 16:46Accelerate Your Growth at the AP3G National Meeting – ASRM
-
Jan 28, 2026, 16:43Debojit Saha: Unraveling Chromosomal Errors in Aging Human Eggs
-
Jan 28, 2026, 16:38Silvia Vannuccini: RBMO Highlights Key Insights on Adenomyosis Awareness
-
Jan 28, 2026, 16:32Maximilian Attwood: Challenging Medical Misogyny in Endometriosis Research
-
Jan 28, 2026, 16:29Ioakeim Sapantzoglou: New Perspectives on Fetal Growth Restriction and Genetic Testing
-
Jan 28, 2026, 16:26Enhancing Pre-Eclampsia Prediction with Doppler Indices – ISUOG